Skip to main content
. 2021 Dec 10;10(24):e022601. doi: 10.1161/JAHA.121.022601

Table 4.

Change in Risk Predictive Metrics by Incorporating GDF‐15 to the Model Including NT‐proBNP and hs‐TnT

c‐statistics

(95% CI)

Category‐free NRI

(95% CI)

IDI

(95% CI)

All‐cause death
Model 2 0.787 (0.748–0.827)
Model 2+log GDF‐15 0.802 (0.764–0.840)* 0.180 (0.069–0.276) 0.028 (0.010–0.055)
Stroke event
Model 2 0.811 (0.766–0.857)
Model 2+log GDF‐15 0.817 (0.773–0.862)* 0.134 (−0.080–0.256) 0.006 (0.000–0.027)*
Cardiac event
Model 2 0.789 (0.749–0.829)
Model 2+log GDF‐15 0.789 (0.749–0.829)* −0.005 (0.068–0.114) 0.000 (−0.001–0.005)

Model 2 was the model incorporating log NT‐proBNP and log hs‐TnT to model 1, which is described in Table 3. GDF‐15, growth differentiation factor‐15; hs‐TnT, high sensitive troponin T; IDI, integrated discrimination improvement; NRI, net reclassification improvement; and NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide.

*

P<0.05.

P<0.01.

P<0.001.